Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Daniel Bowles

Concepts (347)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antineoplastic Agents
30
2024
2051
3.580
Why?
Head and Neck Neoplasms
16
2023
533
3.090
Why?
Salivary Gland Neoplasms
8
2023
33
3.060
Why?
Carcinoma, Squamous Cell
14
2019
620
2.390
Why?
Protein Kinase Inhibitors
14
2024
872
2.320
Why?
Pyridines
11
2024
475
2.140
Why?
Thyroid Neoplasms
9
2024
309
2.030
Why?
Neoplasm Recurrence, Local
7
2023
958
1.780
Why?
Molecular Targeted Therapy
7
2021
385
1.770
Why?
Carcinoma, Non-Small-Cell Lung
8
2023
1045
1.760
Why?
Antineoplastic Combined Chemotherapy Protocols
14
2024
1559
1.660
Why?
Neoplasms
20
2024
2464
1.620
Why?
Protein-Tyrosine Kinases
4
2021
430
1.520
Why?
Lung Neoplasms
10
2023
2328
1.450
Why?
Anilides
6
2024
73
1.440
Why?
Gonanes
7
2016
27
1.420
Why?
Proto-Oncogene Proteins
6
2021
634
1.380
Why?
Biomarkers, Tumor
8
2020
1181
1.340
Why?
Thyroid Carcinoma, Anaplastic
3
2020
35
1.340
Why?
Cetuximab
7
2018
93
1.330
Why?
Adenocarcinoma
7
2024
888
1.310
Why?
Phosphatidylinositol 3-Kinases
8
2017
357
0.870
Why?
Mutation
13
2024
3689
0.820
Why?
Carcinoma
3
2019
214
0.760
Why?
Neoplasm Staging
15
2019
1290
0.740
Why?
Phytotherapy
2
2012
75
0.730
Why?
Drugs, Investigational
2
2011
32
0.730
Why?
Cisplatin
6
2024
297
0.720
Why?
Pyrazoles
5
2023
404
0.680
Why?
Disease-Free Survival
10
2017
647
0.670
Why?
Neoplasms, Second Primary
1
2021
108
0.660
Why?
Papillomaviridae
4
2019
113
0.660
Why?
Antineoplastic Agents, Immunological
2
2018
175
0.660
Why?
Quinolines
5
2024
153
0.650
Why?
Carcinoma, Renal Cell
3
2017
179
0.650
Why?
Taxoids
3
2015
95
0.650
Why?
Humans
89
2024
128418
0.640
Why?
Hedgehog Proteins
3
2015
187
0.630
Why?
Drug Resistance, Neoplasm
8
2024
749
0.620
Why?
Marijuana Smoking
2
2012
239
0.590
Why?
Tumor Suppressor Proteins
2
2018
313
0.590
Why?
Middle Aged
43
2024
30889
0.590
Why?
Pyrimidines
5
2023
445
0.590
Why?
Colorectal Neoplasms
2
2016
746
0.570
Why?
Aged
39
2024
21953
0.570
Why?
Kidney Neoplasms
3
2017
349
0.560
Why?
Carcinoma, Mucoepidermoid
1
2017
16
0.550
Why?
Ubiquitin Thiolesterase
1
2017
42
0.540
Why?
Carcinoma, Transitional Cell
4
2017
60
0.530
Why?
Carcinoma, Ductal
1
2016
11
0.530
Why?
Adenoma, Pleomorphic
1
2016
9
0.530
Why?
Cannabinoids
2
2024
129
0.520
Why?
Sulfones
2
2014
108
0.520
Why?
Gene Rearrangement
2
2018
146
0.520
Why?
Glycine
2
2014
164
0.510
Why?
Maximum Tolerated Dose
5
2017
192
0.480
Why?
Enzyme Inhibitors
3
2014
809
0.450
Why?
Drug Interactions
6
2017
357
0.440
Why?
Melanoma
1
2021
752
0.440
Why?
Pyrroles
1
2014
191
0.430
Why?
Male
44
2024
62858
0.430
Why?
Signal Transduction
8
2018
4826
0.430
Why?
Iodine Radioisotopes
5
2024
142
0.420
Why?
Gene Fusion
3
2023
24
0.420
Why?
Phenylurea Compounds
4
2024
89
0.420
Why?
Receptor Protein-Tyrosine Kinases
2
2012
221
0.410
Why?
Genetic Variation
1
2018
933
0.410
Why?
Female
45
2024
68154
0.410
Why?
Lymph Nodes
4
2017
466
0.400
Why?
Indazoles
3
2019
64
0.400
Why?
Aged, 80 and over
15
2024
7033
0.390
Why?
Treatment Outcome
15
2024
10152
0.390
Why?
Class I Phosphatidylinositol 3-Kinases
4
2017
81
0.380
Why?
Quinazolines
1
2013
243
0.380
Why?
Antibodies, Monoclonal, Humanized
4
2024
755
0.380
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2012
111
0.370
Why?
Neoplasm Metastasis
6
2021
608
0.350
Why?
Proto-Oncogene Proteins c-ret
4
2023
29
0.340
Why?
Adult
26
2024
35300
0.340
Why?
Prognosis
9
2021
3772
0.310
Why?
Papillomavirus Infections
3
2022
290
0.300
Why?
ErbB Receptors
4
2017
601
0.300
Why?
Pharmacogenomic Variants
2
2018
35
0.290
Why?
Nitriles
2
2022
157
0.280
Why?
Urologic Neoplasms
2
2017
25
0.270
Why?
Xenograft Model Antitumor Assays
7
2024
814
0.270
Why?
Carcinoma, Ductal, Breast
1
2007
82
0.270
Why?
Platinum
2
2024
44
0.270
Why?
Mitoxantrone
1
2006
14
0.270
Why?
Enterobacter
1
2006
7
0.260
Why?
Tooth Diseases
1
2006
13
0.260
Why?
Gene Expression Profiling
5
2018
1688
0.250
Why?
Esophageal and Gastric Varices
1
2006
36
0.250
Why?
Enterobacteriaceae Infections
1
2006
36
0.250
Why?
Benzamides
2
2019
194
0.250
Why?
Animals
16
2024
34479
0.250
Why?
Salivary Glands
2
2023
29
0.250
Why?
Oropharyngeal Neoplasms
2
2016
48
0.250
Why?
Acute Kidney Injury
3
2018
773
0.250
Why?
Chemoradiotherapy
4
2020
209
0.240
Why?
Clinical Trials as Topic
3
2018
993
0.240
Why?
Registries
2
2016
1877
0.240
Why?
Serotonin 5-HT3 Receptor Antagonists
1
2024
5
0.240
Why?
Proto-Oncogene Proteins B-raf
2
2024
214
0.230
Why?
Cannabis
1
2011
429
0.230
Why?
Immunotherapy
2
2023
587
0.230
Why?
Receptors, Estrogen
1
2007
424
0.230
Why?
Antiemetics
1
2024
39
0.230
Why?
Urinary Bladder Neoplasms
2
2017
226
0.220
Why?
Models, Biological
3
2024
1691
0.220
Why?
Liver Cirrhosis
1
2006
275
0.220
Why?
Bacteremia
1
2006
190
0.220
Why?
Carcinoma, Adenoid Cystic
1
2023
17
0.220
Why?
Combined Modality Therapy
4
2018
1204
0.220
Why?
Gene Expression Regulation, Neoplastic
3
2019
1351
0.220
Why?
Administration, Oral
3
2014
754
0.210
Why?
Phenylthiohydantoin
1
2022
44
0.200
Why?
Survival Rate
5
2021
1869
0.190
Why?
Medical Marijuana
1
2024
107
0.190
Why?
Referral and Consultation
1
2007
727
0.190
Why?
Breast Neoplasms
2
2019
2132
0.190
Why?
Drug Evaluation, Preclinical
2
2013
168
0.190
Why?
Chemotherapy, Adjuvant
3
2017
376
0.190
Why?
Radiation Pneumonitis
1
2021
28
0.190
Why?
Survival Analysis
4
2020
1263
0.190
Why?
Carcinoma, Neuroendocrine
1
2021
32
0.180
Why?
TOR Serine-Threonine Kinases
2
2016
380
0.180
Why?
Adrenal Cortex Neoplasms
1
2021
60
0.170
Why?
Adrenocortical Carcinoma
1
2021
63
0.170
Why?
Disease Susceptibility
2
2020
331
0.170
Why?
SEER Program
1
2021
206
0.170
Why?
Cystectomy
2
2017
38
0.170
Why?
Gene Expression
2
2015
1456
0.170
Why?
Receptors, Nerve Growth Factor
1
2019
16
0.170
Why?
Kaplan-Meier Estimate
3
2017
853
0.170
Why?
United States
8
2021
13830
0.160
Why?
Leukemia, Myeloid, Acute
1
2006
591
0.160
Why?
Radiosurgery
1
2022
318
0.160
Why?
DNA Mutational Analysis
2
2018
384
0.160
Why?
Tracheal Neoplasms
1
2019
10
0.160
Why?
Positron Emission Tomography Computed Tomography
1
2020
84
0.160
Why?
Lymph Node Excision
2
2017
165
0.160
Why?
Smad4 Protein
1
2019
37
0.160
Why?
Prostatic Neoplasms
1
2006
1011
0.150
Why?
Genetic Heterogeneity
1
2019
57
0.150
Why?
Benzazepines
1
2018
40
0.150
Why?
Genomics
3
2021
715
0.150
Why?
Alphapapillomavirus
2
2016
40
0.150
Why?
Palliative Care
2
2018
713
0.150
Why?
Disease Management
2
2020
587
0.150
Why?
Risk
1
2021
853
0.150
Why?
Chromosome Aberrations
1
2019
148
0.150
Why?
DNA Mismatch Repair
1
2018
47
0.150
Why?
Receptor, ErbB-2
2
2019
325
0.150
Why?
Tissue Fixation
1
2017
33
0.140
Why?
Paraffin Embedding
1
2017
27
0.140
Why?
Oncogenes
1
2018
109
0.140
Why?
Erlotinib Hydrochloride
1
2017
69
0.140
Why?
Smokers
1
2018
137
0.140
Why?
Formaldehyde
1
2017
57
0.140
Why?
Nasopharyngeal Neoplasms
1
2017
16
0.140
Why?
Radiotherapy, Intensity-Modulated
1
2018
128
0.140
Why?
Gene Deletion
1
2019
370
0.140
Why?
Health Services Needs and Demand
1
2019
264
0.140
Why?
Neoplasm Grading
1
2018
283
0.140
Why?
DNA, Neoplasm
1
2017
159
0.140
Why?
Induction Chemotherapy
1
2017
70
0.130
Why?
Gene Frequency
1
2018
504
0.130
Why?
Chemoradiotherapy, Adjuvant
1
2016
41
0.130
Why?
Salivary Ducts
1
2016
2
0.130
Why?
Hospice and Palliative Care Nursing
1
2018
74
0.130
Why?
Laryngeal Neoplasms
1
2016
29
0.130
Why?
Patient Navigation
1
2018
79
0.130
Why?
Prospective Studies
7
2024
7036
0.130
Why?
Carboplatin
1
2016
140
0.130
Why?
Muscle, Smooth
1
2017
145
0.130
Why?
Nomograms
1
2016
47
0.130
Why?
Young Adult
5
2021
12312
0.130
Why?
Dose-Response Relationship, Drug
3
2017
1936
0.130
Why?
Population Surveillance
1
2019
427
0.130
Why?
Database Management Systems
1
2016
48
0.130
Why?
Disease Progression
4
2018
2602
0.130
Why?
Retrospective Studies
8
2021
14454
0.130
Why?
Computational Biology
2
2018
598
0.130
Why?
Incidence
2
2019
2616
0.120
Why?
Angiopoietin-1
1
2015
11
0.120
Why?
Angiopoietin-2
1
2015
15
0.120
Why?
Radiotherapy
1
2016
185
0.120
Why?
Bone Neoplasms
1
2017
229
0.120
Why?
Genetic Testing
1
2018
428
0.120
Why?
Zinc Finger Protein GLI1
1
2014
24
0.120
Why?
Retreatment
1
2014
69
0.120
Why?
Hospice Care
1
2018
198
0.120
Why?
Piperazines
2
2018
336
0.120
Why?
Neoplasms, Unknown Primary
1
2014
13
0.110
Why?
Response Evaluation Criteria in Solid Tumors
1
2014
17
0.110
Why?
Proto-Oncogene Proteins c-akt
1
2016
421
0.110
Why?
Paclitaxel
1
2015
214
0.110
Why?
Neoplastic Stem Cells
1
2018
386
0.110
Why?
Patient Satisfaction
1
2018
641
0.110
Why?
High-Throughput Nucleotide Sequencing
1
2017
484
0.110
Why?
Pilot Projects
2
2015
1564
0.110
Why?
Sulfonamides
1
2017
499
0.110
Why?
Proportional Hazards Models
4
2017
1196
0.110
Why?
Promoter Regions, Genetic
1
2018
1198
0.110
Why?
Veratrum Alkaloids
1
2013
19
0.110
Why?
ras Proteins
1
2014
145
0.110
Why?
Cell Cycle Proteins
2
2014
577
0.100
Why?
PTEN Phosphohydrolase
1
2014
157
0.100
Why?
Proto-Oncogene Proteins p21(ras)
1
2014
258
0.100
Why?
Imatinib Mesylate
1
2012
66
0.100
Why?
Risk Assessment
2
2019
3232
0.100
Why?
Dasatinib
1
2012
51
0.100
Why?
Recombinant Fusion Proteins
1
2015
634
0.100
Why?
Thiazoles
1
2012
115
0.100
Why?
Hematopoietic Stem Cells
1
2015
378
0.100
Why?
Aniline Compounds
1
2012
98
0.100
Why?
Biomarkers
3
2018
3880
0.090
Why?
Mice
7
2024
16602
0.090
Why?
Smoking
1
2019
1460
0.090
Why?
Biological Availability
1
2011
122
0.090
Why?
Proto-Oncogene Proteins c-met
1
2012
74
0.090
Why?
Imidazoles
1
2012
226
0.090
Why?
Adolescent
5
2022
20179
0.090
Why?
Propensity Score
3
2017
264
0.090
Why?
Carcinoma, Basal Cell
1
2012
73
0.090
Why?
Phosphatidylinositol 3-Kinase
1
2011
26
0.090
Why?
Evidence-Based Medicine
2
2012
711
0.090
Why?
Vascular Endothelial Growth Factor A
2
2024
500
0.090
Why?
Tumor Microenvironment
1
2015
623
0.090
Why?
Cell Line, Tumor
4
2024
3184
0.090
Why?
Algorithms
1
2018
1618
0.090
Why?
Phenotype
1
2018
3044
0.080
Why?
Genetic Predisposition to Disease
1
2018
2264
0.080
Why?
Kidney
1
2017
1302
0.080
Why?
Adaptation, Psychological
1
2014
616
0.080
Why?
Brain Neoplasms
1
2018
1163
0.080
Why?
Receptors, Vascular Endothelial Growth Factor
2
2024
89
0.080
Why?
Multivariate Analysis
3
2017
1484
0.080
Why?
Cohort Studies
4
2022
5388
0.070
Why?
Axilla
1
2007
43
0.070
Why?
Neoadjuvant Therapy
2
2022
381
0.070
Why?
Clinical Trials, Phase I as Topic
2
2019
50
0.070
Why?
RNA, Messenger
1
2014
2675
0.070
Why?
Caregivers
1
2014
810
0.070
Why?
Sentinel Lymph Node Biopsy
1
2007
108
0.070
Why?
Mastectomy
1
2007
131
0.070
Why?
Transcription Factors
1
2014
1628
0.070
Why?
Ligation
1
2006
86
0.060
Why?
Stress, Psychological
1
2014
1060
0.060
Why?
Creatinine
2
2018
475
0.060
Why?
Pain
1
2011
757
0.060
Why?
Fatal Outcome
1
2006
300
0.060
Why?
Lymphatic Metastasis
2
2017
318
0.060
Why?
Neoplasm Invasiveness
2
2017
480
0.060
Why?
Double-Blind Method
2
2021
1848
0.060
Why?
Receptors, Progesterone
1
2007
341
0.060
Why?
Granisetron
1
2024
5
0.060
Why?
Quinuclidines
1
2024
9
0.060
Why?
Gastrointestinal Hemorrhage
1
2006
119
0.060
Why?
Ondansetron
1
2024
15
0.060
Why?
Risk Factors
1
2019
9704
0.060
Why?
Isoquinolines
1
2024
41
0.060
Why?
Skin Neoplasms
1
2012
832
0.060
Why?
Neoplasm Proteins
1
2007
421
0.060
Why?
Glomerular Filtration Rate
2
2018
681
0.060
Why?
Demography
2
2015
277
0.060
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2023
81
0.050
Why?
Benzimidazoles
1
2024
157
0.050
Why?
Recurrence
2
2018
996
0.050
Why?
Databases, Factual
2
2019
1269
0.050
Why?
Androgen Antagonists
1
2022
79
0.050
Why?
Four-Dimensional Computed Tomography
1
2021
28
0.050
Why?
Quality of Life
1
2013
2680
0.050
Why?
Immunohistochemistry
2
2018
1664
0.050
Why?
Pulmonary Ventilation
1
2021
76
0.050
Why?
Receptors, Androgen
1
2022
143
0.050
Why?
Radiotherapy Planning, Computer-Assisted
1
2021
123
0.050
Why?
Receptor, trkA
1
2019
16
0.040
Why?
Receptor, trkC
1
2019
10
0.040
Why?
Clinical Trials, Phase II as Topic
1
2019
71
0.040
Why?
Receptor, trkB
1
2019
31
0.040
Why?
Trastuzumab
1
2019
100
0.040
Why?
Extracellular Signal-Regulated MAP Kinases
1
2020
163
0.040
Why?
Radiotherapy, Image-Guided
1
2018
33
0.040
Why?
Phthalazines
1
2018
40
0.040
Why?
In Situ Hybridization, Fluorescence
1
2019
313
0.040
Why?
Organic Cation Transporter 2
1
2017
8
0.040
Why?
Glutathione S-Transferase pi
1
2017
9
0.040
Why?
Multidrug Resistance-Associated Proteins
1
2017
36
0.040
Why?
Retroperitoneal Space
1
2017
16
0.040
Why?
Organic Cation Transport Proteins
1
2017
26
0.030
Why?
Urinary Diversion
1
2017
12
0.030
Why?
Membrane Glycoproteins
1
2019
466
0.030
Why?
National Cancer Institute (U.S.)
1
2017
43
0.030
Why?
Margins of Excision
1
2017
37
0.030
Why?
Social Work
1
2018
83
0.030
Why?
Tumor Cells, Cultured
1
2019
930
0.030
Why?
Laryngectomy
1
2016
14
0.030
Why?
Immunophenotyping
1
2018
311
0.030
Why?
Oncologists
1
2017
35
0.030
Why?
Hospitals, Veterans
1
2018
256
0.030
Why?
Kidney Function Tests
1
2017
145
0.030
Why?
Disease Models, Animal
2
2018
3937
0.030
Why?
Pelvis
1
2017
101
0.030
Why?
Carcinogenesis
1
2018
209
0.030
Why?
Viral Core Proteins
1
2016
21
0.030
Why?
Cation Transport Proteins
1
2017
129
0.030
Why?
Anti-Bacterial Agents
1
2006
1663
0.030
Why?
Regression Analysis
1
2018
978
0.030
Why?
Heart
1
2020
635
0.030
Why?
Radiotherapy, Adjuvant
1
2016
209
0.030
Why?
Internationality
1
2016
148
0.030
Why?
Random Allocation
1
2016
343
0.030
Why?
Robotic Surgical Procedures
1
2017
109
0.030
Why?
Antibodies, Neoplasm
1
2015
35
0.030
Why?
Biopsy, Large-Core Needle
1
2014
13
0.030
Why?
Myocardium
1
2020
965
0.030
Why?
Analysis of Variance
1
2017
1269
0.030
Why?
Bone Marrow
1
2015
267
0.030
Why?
Receptor, Notch2
1
2013
15
0.030
Why?
Receptor Cross-Talk
1
2013
21
0.030
Why?
Receptor, Notch1
1
2013
61
0.030
Why?
Pandemics
1
2021
1476
0.030
Why?
Metabolic Clearance Rate
1
2012
103
0.020
Why?
Gene Silencing
1
2013
185
0.020
Why?
Psychiatric Status Rating Scales
1
2014
528
0.020
Why?
Transcriptome
1
2018
881
0.020
Why?
Needs Assessment
1
2014
359
0.020
Why?
Nausea
1
2012
107
0.020
Why?
Logistic Models
1
2017
1974
0.020
Why?
Area Under Curve
1
2012
279
0.020
Why?
Vomiting
1
2012
126
0.020
Why?
Diarrhea
1
2012
177
0.020
Why?
Mice, Nude
1
2013
682
0.020
Why?
Blotting, Western
1
2013
1164
0.020
Why?
Drug Administration Schedule
1
2012
751
0.020
Why?
Fatigue
1
2012
317
0.020
Why?
Cell Proliferation
1
2017
2344
0.020
Why?
Time Factors
1
2019
6482
0.020
Why?
Lung
1
2021
3743
0.020
Why?
Age Factors
1
2016
3103
0.020
Why?
Colorado
1
2018
4375
0.020
Why?
Follow-Up Studies
1
2016
4892
0.020
Why?
Cytokines
1
2015
1983
0.020
Why?
Surveys and Questionnaires
1
2018
5362
0.020
Why?
Cross-Sectional Studies
1
2014
5039
0.010
Why?
Bowles's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)